Uses
ChemicalBook > CAS DataBase List > BMS-986165

BMS-986165

Uses
Product Name
BMS-986165
CAS No.
1609392-27-9
Chemical Name
BMS-986165
Synonyms
Deucravacitinib;6-(cyclopropanecarboxamido)-4-((2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl) phenyl)amino)-N-(methyl-d3)pyridazine-3-carboxamide;Tyk2-IN-4;Deucravacitinb;BMS-986165 API;Deucravacitinib (TYK2-IN-4;Deucravacitinib(BMS986165);TYK2-IN-4;BMS986165;BMS-986165;BMS 986165;DeucravacitinibQ: What is Deucravacitinib Q: What is the CAS Number of Deucravacitinib;6-cyclopropaneamido-4-{[2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl]amino}-N-(2H?)methylpyridazine-3-carboxamide
CBNumber
CB74808663
Molecular Formula
C20H22N8O3
Formula Weight
422.45
MOL File
1609392-27-9.mol
More
Less

BMS-986165 Property

storage temp. 
Store at -20°C
solubility 
DMF: 1 mg/ml; DMSO: 1 mg/ml; DMSO:PBS (pH 7.2) (1:2): 0.33 mg/ml
form 
A crystalline solid
More
Less

Hazard and Precautionary Statements (GHS)

Symbol(GHS)
Signal word
Danger
Hazard statements

H372Causes damage to organs through prolonged or repeated exposure

Precautionary statements

P260Do not breathe dust/fume/gas/mist/vapours/spray.

P264Wash hands thoroughly after handling.

P264Wash skin thouroughly after handling.

P270Do not eat, drink or smoke when using this product.

P314Get medical advice/attention if you feel unwell.

P501Dispose of contents/container to..…

More
Less

N-Bromosuccinimide Price

ChemScene
Product number
CS-0065044
Product name
BMS-986165
Purity
99.79%
Packaging
10mg
Price
$350
Updated
2021/12/16
ChemScene
Product number
CS-0065044
Product name
BMS-986165
Purity
99.79%
Packaging
50mg
Price
$850
Updated
2021/12/16
DC Chemicals
Product number
DC12174
Product name
Deucravacitinib(BMS986165)
Purity
>98%
Packaging
250mg
Price
$1100
Updated
2021/12/16
DC Chemicals
Product number
DC12174
Product name
Deucravacitinib(BMS986165)
Purity
>98%
Packaging
1g
Price
$2200
Updated
2021/12/16
Crysdot
Product number
CD31005021
Product name
6-[(Cyclopropylcarbonyl)amino]-4-{[2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl]amino}-N-(2H3)methyl-3-pyridazinecarboxamide
Purity
98%
Packaging
5mg
Price
$450
Updated
2021/12/16
More
Less

BMS-986165 Chemical Properties,Usage,Production

Uses

BMS-986165 is a novel oral selective TYK2 inhibitor with a unique mechanism of action that is expected to provide a promising oral option to help patients effectively manage their psoriasis.

Uses

Deucravacitinib is a tyrosine kinase 2 inhibitor which can be useful in the treatment of systemic lupus erythematosus.

General Description

Deucravacitinib, a highly selective allosteric TYK2 inhibitor, received its first approval from the FDA in 2022 for the treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy protein and lipid kinases and pseudokinases with the exception of BMPR2 (IC50 = 193 nM) and JAK1 JH2 pseudokinase domain (IC50 = 1 nM). Despite its potent affinity for JAK1 JH2, deucravacitinib elicited low functional activity in a JAK1/JAK3-dependent IL-2 stimulated cellular assay. BMS-986202 displays >10,000-fold selectivity for TYK2 JH2 over a diverse panel of 273 kinases and pseudokinases that include JAK family members. Like deucravacitinib, its high binding affinity to JAK1 JH2 (IC50 = 7.8 nM) did not translate to functional activity in the cellular assay.

Pharmacokinetics

The crystalline free base form of deucravacitinib exhibited poor aqueous solubility (5.2 μg/mL), which was still acceptable for preclinical studies. It showed moderate half-lives of 4?5 h across species (mouse, dog, and monkey). Excellent exposures and high bioavailability (F > 85%) in mice, dogs, and monkeys were obtained from oral pharmacokinetic studies at a 10 mpk dose. Following oral administration of deucravacitinib, the major metabolite in human plasma was the cyclopropyl carboxamide hydrolytic cleavage product 4 (6-amino-4-((2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl)amino)-N-methylpyridazine-3-carboxamide).

BMS-986165 Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

BMS-986165 Suppliers

TargetMol Chemicals Inc.
Tel
+1-781-999-5354 +1-00000000000
Email
marketing@targetmol.com
Country
United States
ProdList
19892
Advantage
58
InvivoChem
Tel
+1-708-310-1919 +1-13798911105
Fax
708-557-7486
Email
sales@invivochem.cn
Country
United States
ProdList
6393
Advantage
58
BOC Sciences
Tel
+1-631-485-4226
Fax
1-631-614-7828
Email
inquiry@bocsci.com
Country
United States
ProdList
19553
Advantage
58
Aladdin Scientific
Tel
+1-833-552-7181
Email
sales@aladdinsci.com
Country
United States
ProdList
52927
Advantage
58
More
Less

View Lastest Price from BMS-986165 manufacturers

hebei hongtan Biotechnology Co., Ltd
Product
BMS-986165 API 1609392-27-9
Price
US $100.00-80.00/KG
Min. Order
1KG
Purity
99.9%
Supply Ability
500
Release date
2024-03-18
hebei hongtan Biotechnology Co., Ltd
Product
Deucravacitinib 1609392-27-9
Price
US $20.00/g
Min. Order
100g
Purity
99.9%
Supply Ability
1000kg
Release date
2024-05-17
Wuhan Senwayer Century Chemical Co.,Ltd
Product
BMS-986165 1609392-27-9
Price
US $0.00/KG
Min. Order
1KG
Purity
99% min
Supply Ability
20 TONS
Release date
2023-02-17

1609392-27-9, BMS-986165Related Search:


  • Tyk2-IN-4
  • TYK2-IN-4;BMS986165;BMS-986165;BMS 986165
  • 6-(cyclopropanecarboxamido)-4-((2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl) phenyl)amino)-N-(methyl-d3)pyridazine-3-carboxamide
  • Deucravacitinib
  • Deucravacitinib(BMS986165)
  • Deucravacitinib (TYK2-IN-4
  • 6-cyclopropaneamido-4-{[2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl]amino}-N-(2H?)methylpyridazine-3-carboxamide
  • DeucravacitinibQ: What is Deucravacitinib Q: What is the CAS Number of Deucravacitinib
  • Janus kinase,inhibit,JAK,Interleukin Related,Interferon-alpha/beta receptor,BMS 986165,Interferon-α/β receptor,IFNAR,Inhibitor,Deucravacitinib,BMS986165
  • 6-[(Cyclopropylcarbonyl)amino]-4-[[2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl]amino]-N-(methyl-d3)-3-pyridazinecarboxamide
  • 6-(cyclopropanecarbonylamino)-4-[2-methoxy-3-(1-methyl-1,2,4-triazol-3-yl)anilino]-N-(trideuteriomethyl)pyridazine-3-carboxamide
  • Deucravacitinb
  • BMS-986165 API
  • 1609392-27-9
  • API
  • APIS
  • API